Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus.
Claudia Mendoza-PintoClaudia Mendoza-PintoSocorro Méndez-MartínezTania Mogollán-DelfínPamela Munguía-RealpozoEfrén Herrera-RoblesIvet Etchegaray-MoralesJosé Luis Gálvez-RomeroÁlvaro Joaquín Montel-JarquínAurelio López-ColomboPublished in: Clinical rheumatology (2019)
We found a high frequency of H. pylori infection in SLE patients. The severity of SLE and reception of gastroprotective therapy do not seem to be related to H. pylori infection. Immunosuppressive therapy may not be protective against H. pylori infection in SLE patients.Key Points• In patients with systemic lupus erythematosus (SLE), the frequency of Helicobacter pylori infection was 39% and gastric erosions were frequent.• Disease activity, chronic damage, gastroprotective drugs, and immunosuppressive therapy may not affect the prevalence of H. pylori infection in SLE patients.
Keyphrases
- systemic lupus erythematosus
- disease activity
- helicobacter pylori infection
- end stage renal disease
- high frequency
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis
- prognostic factors
- peritoneal dialysis
- helicobacter pylori
- oxidative stress
- stem cells
- juvenile idiopathic arthritis
- patient reported